An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators ...
An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators ...
Penn Medicine professor Carl June was recently awarded the Broermann Medical Innovation Award 2025 for his work on utilizing CAR-T cells in cancer therapy. Modifying T-cells with chimeric antigen ...
Representative images of DP cells collected from the blood of patients with breast cancer. The cells show the distinctive expression of both epithelial (cytokeratin, in red) and leukocyte (CD45, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results